BC006779 Inhibitors
BC006779 inhibitors are chemical compounds that directly or indirectly influence the function of BC006779, a protein known to regulate vesicle-mediated transport. Inhibitors such as Brefeldin A, Wortmannin, LY294002, Nocodazole, Vinblastine, Monensin, Chlorpromazine, Dynasore, Exo1, Pitstop 2, Latrunculin B, and Genistein can lead to the decreased functional activity of BC006779 through specific signaling pathways or biological processes that it is directly involved in.
For instance, Brefeldin A inhibits protein transport from the endoplasmic reticulum to the Golgi apparatus, which candisrupt the formation and function of vesicles that BC006779 regulates. Similarly, Wortmannin and LY294002 are PI3K inhibitors that can disrupt vesicle trafficking by inhibiting the PI3K-dependent pathway, thereby affecting BC006779's functional activity. Nocodazole and Vinblastine are microtubule-disrupting agents that inhibit vesicle transport along the microtubules, a process that BC006779 is involved in. Monensin alters ion gradients to disrupt intracellular trafficking, which can lead to the inhibition of BC006779's functional activity.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A is a fungal metabolite that inhibits protein transport from the endoplasmic reticulum to the Golgi apparatus. BC006779 is involved in the regulation of vesicle-mediated transport, and the inhibition of protein transport by Brefeldin A can disrupt the formation and function of these vesicles, leading to decreased functional activity of BC006779. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3K inhibitor that can disrupt vesicle trafficking by inhibiting the PI3K-dependent pathway. As BC006779 is involved in vesicle trafficking, Wortmannin's inhibition of PI3K can lead to decreased functional activity of BC006779. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can disrupt vesicle trafficking by inhibiting the PI3K-dependent pathway. As BC006779 is involved in vesicle trafficking, LY294002's inhibition of PI3K can lead to decreased functional activity of BC006779. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
Nocodazole is a microtubule-depolymerizing agent. As BC006779 is involved in vesicle transport along microtubules, Nocodazole's depolymerization of microtubules can disrupt this transport process, leading to decreased functional activity of BC006779. | ||||||
Vinblastine Sulfate | 143-67-9 | sc-201447 sc-201447A sc-201447B sc-201447C | 10 mg 50 mg 100 mg 1 g | $109.00 $412.00 $561.00 $2244.00 | 9 | |
Vinblastine is a microtubule-disrupting agent that inhibits microtubule dynamics, leading to the disruption of vesicle transport along the microtubules. Since BC006779 is involved in vesicle transport, the disruption of microtubule dynamics by Vinblastine can lead to decreased functional activity of BC006779. | ||||||
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin is a sodium ionophore that disrupts intracellular trafficking by altering ion gradients. Given BC006779's role in vesicle trafficking, Monensin's alteration of ion gradients can disrupt the functional activity of BC006779. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
Chlorpromazine inhibits clathrin-mediated endocytosis. As BC006779 is involved in the regulation of vesicle-mediated transport, Chlorpromazine's inhibition of clathrin-mediated endocytosis can lead to decreased functional activity of BC006779. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Dynasore inhibits the GTPase activity of dynamin, a protein involved in vesicle formation. BC006779's function in vesicle-mediated transport can be disrupted by Dynasore's effect on dynamin, leading to a decrease in BC006779's functional activity. | ||||||
Exo1 | 461681-88-9 | sc-200752 sc-200752A | 10 mg 50 mg | $84.00 $297.00 | 4 | |
Exo1 is an inhibitor of exocyst complex function. The inhibition of the exocyst complex can disrupt vesicle trafficking, a process in which BC006779 is involved, leading to a decrease in BC006779's functional activity. | ||||||
Pitstop 2 | 1419320-73-2 | sc-507418 | 10 mg | $360.00 | ||
Pitstop 2 is an inhibitor of clathrin-mediated endocytosis. As BC006779 is involved in vesicle-mediated transport, Pitstop 2's inhibition of clathrin-mediated endocytosis can decrease the functional activity of BC006779. | ||||||